Your session is about to expire
← Back to Search
Study Summary
This trial is testing whether Joyuus improves maternal functioning in postpartum moms. Results will measure depression, anxiety, resilience, social support, and knowledge.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I don't have health issues that would affect my participation.I gave birth within the last 6 months.I am 18 years old or older.
- Group 1: active intervention group
- Group 2: standard care control group
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any particular demographics that are ideal candidates for this research study?
"Eligibility requirements for this medical research state that participants should have maternal health and be aged between 18 to 99 years old. A total of 132 people will be accepted into the trial."
Are there any vacancies available for enrollment in this clinical trial?
"Evidently, this clinical trial is no longer recruiting patients. Initially posted on October 1st 2023 and most recently updated on May 24th 2023; nevertheless, there are 8 alternative studies that remain open to enrolment."
Are applicants younger than fifty-five years of age eligible to join this experiment?
"According to the enrolment requirements, this clinical trial is limited to individuals between 18 and 99 years of age. For minors and seniors who are not eligible for this study, there exist two separate trials that cater specifically to those under 18 and five distinct studies targeting patients above 65."
Share this study with friends
Copy Link
Messenger